Compare Funko Inc (FNKO) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Funko Inc vs Medpace Holdings Inc — how do they compare? Funko Inc trades at $6.43 (market cap $363.97M), while Medpace Holdings Inc trades at $611.57 (market cap $16.82B). The key difference: Medpace Holdings Inc is far larger — about 46.2× Funko Inc's market cap, and Medpace Holdings Inc is more actively traded (223,093 versus 1,422,651). Which is the better fit depends on your goals — on Pluang, investors hold Funko Inc for 33 Days and Medpace Holdings Inc for 14 Days on average.
| FNKO | MEDP | |
|---|---|---|
Market Cap | $363.97M | $16.82B |
Volume | 1,422,651 | 223,093 |
Sector | Consumer Cyclical | Health |
52-Week High | $7.10 | $630.19 |
52-Week Low | $2.81 | $393.42 |
Typical Hold Time | 33 Days | 14 Days |
Enterprise Value | $584.62M | $16.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FNKO trades at $6.44, up 2.06% today, with strong technical momentum and bullish moving average signals. The company shows improving fundamentals with recent earnings beats and raised EBITDA guidance, though profitability remains challenged with negative net margins. Analyst sentiment is mixed with a 'Hold' consensus and $7.58 price target, representing 17.7% upside potential from current levels.
Investment outlook balances operational improvements against persistent profitability challenges. The stock offers potential upside from continued execution of the 'Make Culture POP!' strategy and margin expansion, but faces risks from consumer discretionary spending volatility and competitive pressures in the collectibles market.
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Funko Inc
Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
